Uniphar PLC (GB:UPR) has released an update.
Uniphar PLC, a diversified healthcare services company, has reported a robust first half of 2024 with a 6.3% EBITDA increase to €55.9 million and a 9.9% rise in gross profit across all divisions. The company’s Pharma division notably achieved a 20.5% growth in gross profit, contributing to a solid interim dividend growth of 5%. Uniphar’s strategic investments and infrastructure improvements signal a confident stride towards meeting their ambitious €200 million EBITDA target in the medium term.
For further insights into GB:UPR stock, check out TipRanks’ Stock Analysis page.
